Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Merck Millipore Live Lab Tour 2012 to Visit Science Zones in Europe

Published: Monday, April 23, 2012
Last Updated: Monday, April 23, 2012
Bookmark and Share
The “Live Lab Tour” will be ready to roll on 15 May. This innovative concept brings latest Merck Millipore technologies to the workplace, with one-to-one planned meetings available at each site.

Merck Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany has announced the schedule for the Merck Millipore Live Lab Tour 2012 that will visit nine science parks and institutions in Europe starting in May.

The “Live Lab,” a 60-square-meter exhibition space housed in an eye-catching coach-style vehicle, is aLLT-visual-(3).gif novel way to bring information about new technologies right to the workplace. Keltoum Benchikh, Lab Water Head of Global Marketing-Communications, explains that the Live Lab Tour concept is part of a portfolio of marketing communications tools designed to present product information in the easiest, most accessible manner possible. “Live Lab visitors will discover our product offering in situ, and will get actual hands-on experience working with Merck Millipore equipment and other materials,” she says. “In addition, Merck Millipore experts will be present at each site to discuss best practices that will help visitors optimize protocols and improve their laboratory work flows,” she adds.

Three laboratories will be set up within the vehicle: a pharmaceutical lab, an academic research lab, and a food and beverages lab. All will be equipped with the Merck Millipore solutions required to perform actual experiments.

For visitors who would like to discuss their specific situations in more detail, special one-to-one sessions with Merck Millipore experts are available at each site from 10:00 am to 3:30 pm every day.

Schedule: Merck Millipore Live Lab Tour 2012
UK – London: 15 May, University College London
UK – London: 16 May, Imperial College
UK – Oxford: 17 May, Milton Science Park
UK – Newcastle: 21 May, Centre for Life
NL – Utrecht: 24 May, Universiteit Utrecht
BE – Liège: 29 May, Université de Liège
FR – Molsheim: 31 May, Merck Millipore
IT – Milan: 5 June, INFN (Italian National Institute of Nuclear Physics)


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Millipore Announces Incoming CEO and President
Udit Batra, Ph.D. will be responsible for the organization’s strategic direction to drive growth and product innovation as well as oversight of the worldwide operations.
Tuesday, April 15, 2014
Merck KGaA Passes EXCiPACT Audit for Certification as Provider of Pharmaceutical Excipients
Ensures current GMP and GDP requirements applied to pharmaceutical excipients through a recognized auditing and certification process.
Friday, August 02, 2013
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!